The Gross Margin of Enanta Pharmaceuticals Inc (ENTA) is
100.00%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date |
Value |
| 2025-09-30 |
100.00%
|
| Ticker |
Name |
Value |
|
ADAG
|
Adagene Inc.
|
7775.20%
|
|
HRTX
|
Heron Therapeutics Inc
|
73.31%
|
|
950220.KQ
|
Neoimmunetech Inc
|
7775.20%
|
|
LXRX
|
Lexicon Pharmaceuticals, Inc.
|
99.45%
|
|
STRO
|
Sutro Biopharma Inc
|
7775.20%
|
|
ABBV
|
AbbVie Inc.
|
71.62%
|
|
CPRX
|
Catalyst Pharmaceuticals, Inc.
|
85.19%
|
|
EGRX
|
Eagle Pharmaceuticals Inc
|
70.03%
|
|
ESPR
|
Esperion Therapeutics, Inc.
|
67.95%
|
|
MDXG
|
MiMedx Group, Inc.
|
82.56%
|
|
ONPH
|
Oncology Pharma Inc
|
44.62%
|
|
REGN
|
Regeneron Pharmaceuticals, Inc.
|
86.56%
|
|
RNA
|
Atrium Therapeutics Inc
|
7775.20%
|
|
CLDX
|
Celldex Therapeutics, Inc.
|
100.00%
|
|
GILD
|
Gilead Sciences, Inc.
|
78.84%
|
|
MNKD
|
MannKind Corporation
|
77.77%
|
|
PGEN
|
Precigen, Inc.
|
50.20%
|
|
950160.KQ
|
Kolon TissueGene Inc
|
13.28%
|
|
950200.KQ
|
Psomagen Inc
|
24.48%
|
|
CVM
|
CEL-SCI Corp
|
7775.20%
|
|
MGTX
|
MeiraGTx Holdings PLC
|
94.05%
|
|
AMGN
|
Amgen Inc
|
70.78%
|
|
CDMO
|
Avid Bioservices Inc
|
5.23%
|
|
HGEN
|
Humanigen Inc
|
7775.20%
|
|
RCEL
|
AVITA Medical Inc
|
83.26%
|
|
VRTX
|
Vertex Pharmaceuticals Incorporated
|
86.24%
|
|
XENE
|
Xenon Pharmaceuticals Inc.
|
7775.20%
|
|
ALT
|
Altimmune, Inc.
|
100.47%
|
|
ANIK
|
Anika Therapeutics Inc
|
56.56%
|
|
CRIS
|
Curis Inc
|
99.52%
|
|
FLXN
|
Flexion Therapeutics Inc
|
77.50%
|
|
IMAB
|
I-Mab
|
100.00%
|
|
MRNA
|
Moderna, Inc.
|
70.32%
|
|
TH.TO
|
Theratechnologies Inc
|
76.19%
|
|
AQB
|
AquaBounty Technologies Inc
|
-518.02%
|
|
ATNX
|
Athenex Inc
|
25.97%
|
|
KDMN
|
Kadmon Holdings Inc
|
75.87%
|